Story | Nov 27, 2013 | 3:47 PM
A collection of news and information related to Orexigen Therapeutics, Inc. published by this site and its partners.
Top Orexigen Therapeutics, Inc. Articles see all
Displaying items 1-4
Story | Dec 18, 2013 | 3:15 PMDec 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets
Story | Nov 25, 2013 | 4:31 AM
Nov 25 (Reuters) - Orexigen Therapeutics Inc said study data showed its experimental obesity drug did not increase heart-related risks, sending its shares up 28 percent in premarket trading. The drug, Contrave, was previously denied approval by the U.S....
Story | Mar 29, 2012 | 4:27 PM